Skye Bioscience, Inc. (SKYE) income statement
SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.79−0.24 (-23.61%)
Close on Nov 19, 2026Market cap $27.87MP/E –Yield –
Skye Bioscience, Inc. financial ratios
See a number that looks wrong?